Back to search

Institutional Repository of Vilnius University

Vulvovaginalinė atrofija po onkoginekologinių ligų gydymo: etiologija, epidemiologija, diagnostika, pagalbos pacientėms galimybės (literatūros apžvalga) /

Abstract

dc:description

Aim: Review the etiology, epidemiology, diagnostics and treatment options of vulvovaginal atrophy that occurs following oncogynecologic treatment. Objectives: 1) Describe etiology; 2) Investigate prevalence and risk factors; 3) Describe diagnostic methods; 4) Investigate treatment methods; 5) Review new treatments. Methods: Literature review was conducted using the PubMed and MEDLINE databases. Results: 10 clinical trials in epidemiology review showed prevalence varying from 19% to 91%, potentially attributed to variances in diagnostic techniques and time since radiotherapy. Treatment review included 33 trials (11 laser, 5 non-hormonal, 4 phytoestrogens, 3 radiofrequency, 3 injections, 2 vitamins D and E, 2 local oxytocin, 1 local tamoxifen, 1 pelvic muscle training, 1 dilatators). Conclusions: Vulvovaginal atrophy stems from iatrogenic menopause and radiotherapy-induced vaginal mucosa thinning; Prevalence varies (19%-91%) with risk factors such as age, combined treatment, external radiotherapy, radiotherapy dosage and aromatase inhibitor use; Suggested diagnostic criteria include (1) perception of dryness or/and other subjective symptoms; (2) vaginal pH >5 and lowered Vaginal Maturation Index (3) at least one objective sign; Treatments mirror those for natural menopause; Safety concerns revolve around estrogen therapy and hormone sensitive cancer recurrence, though low-dose local estrogen therapy appears safe. Early use of non-hormonal remedies post-radiotherapy may prevent symptoms; Laser, radiofrequency, and injections show promise with minimal side effects and hormone-independent mechanisms. Most studies suggest that these methods have a beneficial impact on at least one aspect of vulvovaginal atrophy. Enhanced positive outcomes are achieved through the combination of these methods.

Degree

thesis:*
Grantor dc:publisher
Institutional Repository of Vilnius University
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Narutytė, Ramunė,

Rights

dc:rights
Statement dc:rights
  • info:eu-repo/semantics/openAccess
Language dc:language
lit

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Vilnius University
Base URL
epublications.vu.lt/oai
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Narutytė, Ramunė,. Vulvovaginalinė atrofija po onkoginekologinių ligų gydymo: etiologija, epidemiologija, diagnostika, pagalbos pacientėms galimybės (literatūros apžvalga) /. Institutional Repository of Vilnius University, 2024. https://repository.vu.lt/VU:ELABAETD210540309&prefLang=en_US